NL-OMON25198招募中不适用
Pharmacokinetic evaluation of long-term Xolair-therapy in severe asthma patients
Medical Centre Leeuwarden0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Severe asthma patients, receiving more than 12 months of omalizumab therapy, >18 months old, able to sign informed consent.
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Protocol Number; CIGE025F1401Allergic rhinitisJPRN-jRCT2031200378Sugimoto Toshiya30
已完成
不适用
Long Term Use Of Xalacom In Patients Glaucoma Or Ocular HypertensionGlaucomaOcular HypertensionNCT01191008Pfizer's Upjohn has merged with Mylan to form Viatris Inc.661
进行中（未招募）
不适用
Mechanism of action of Xolair (omalizumab) as treatment for hivesEUCTR2014-005127-27-NLMC Utrecht
已完成
4 期
Markers of Efficacy of Xolair (Omalizumab) in Chronic Spontaneous Urticariahives10002426urticariaNL-OMON43836niversitair Medisch Centrum Utrecht30
已完成
2 期
PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic BladderBladder, NeurogenicNCT00340704Boehringer Ingelheim143